Drew Moghanaki
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
Drew Moghanaki
Oct 20, 2024, 11:27 |
Insight
Nicholas van As: Delighted to share the results of PACE B trial
Nicholas van As, Medical Director at The Royal Marsden NHS Foundation Trust, shared his recent…
Oct 16, 2024, 15:08 |
Insight
The utility of ctDNA clearance for personalizing consolidation immunotherapy after CRT for stage III NSCLC
Drew Moghanaki shared a post on X: "A new publication from Max Diehn's group re-demonstrates the…
Oct 7, 2024, 17:16 |
Insight
Drew Moghanaki: IMRT with MR-linac and VMAT for lung SABR
Drew Moghanaki shared a post on X about a paper by Jong Min Park et…
Oct 1, 2024, 16:39 |
Insight
Drew Moghanaki: Evaluating the first 100 participants treated with lung SBRT through 2022 of the VALOR study
Drew Moghanaki shared a post on X about a recent paper by Timothy Ritter et…
Sep 30, 2024, 16:32 |
Insight
Drew Moghanaki: The embargo has been lifted on the results for the LU-005 trial for LS-SCLC
Drew Moghanaki shared a post on X: "The embargo has been lifted on the results…
Sep 29, 2024, 15:41 |
Blog
Drew Moghanaki: Insights on patients over 75 in the CALGB 140503 study
Drew Moghanaki shared the following on X: “I’ve been thinking a lot about the patients…
Sep 8, 2024, 13:51 |
Societies
20 Posts Not To Miss from Day 1 of WCLC24
The International Association for the Study of Lung Cancer (IASLC) is a global, multidisciplinary organization…
Sep 7, 2024, 09:37 |
Insight
An article for those who worry about single-fraction lung SBRT
Drew Moghanaki shared a post on X: "Here's an article for those who worry about…
Sep 6, 2024, 07:04 |
Blog
The first phase III trials of SBRT+/- Checkpoint inhibitors for stage 1 NSCLC
Corinne Faivre-Finn, Professor of Thoracic Radiation Oncology at the University of Manchester, shared a post…
Sep 2, 2024, 08:32 |
Insight
Drew Moghanaki: Single fraction lung SBRT has become my go-to for medically inoperable stage I NSCLC
Drew Moghanaki shared a post on X about a paper by Gregory Videtic et al.…
Aug 31, 2024, 08:18 |
Blog
Drew Moghanaki: Why WCLC 24 will be my favorite meeting of the year
Drew Moghanaki, Co-Chair of VA Lung Precision Oncology Program Biomarker Subworkgroup at U.S. Department of…
Aug 27, 2024, 03:21 |
Insight
An open letter to policy makers: Effects of the climate crisis on cancer
Drew Moghanaki shared on X: “Dear Colleagues. I invite everyone to ‘add your name to…
Aug 26, 2024, 21:18 |
Blog
Drew Moghanaki: The importance of intraop LN sampling
Drew Moghanaki shared on X: “As a lung cancer specialist, I stand by the importance…
Aug 24, 2024, 13:55 |
Blog
Drew Moghanaki: Why it's crucial to engage patients when developing informational statements
Drew Moghanaki shared on X: "Patient communication is more effective when using "testimonials" versus "informational…
Aug 21, 2024, 08:32 |
Blog
Drew Moghanaki: There is more than one way to think about how lung cancers develop
Drew Moghanaki shared a post on X: "These figures shared by Steve Dubinett at UCLA…
Aug 5, 2024, 07:44 |
Blog
Drew Moghanaki: US is united to drive down lung cancer mortality
Drew Moghanaki shared on X: " A group of powerful resources in the US unite to…
Jul 25, 2024, 01:13 |
Blog
Drew Moghanaki: GO2 for Lung Cancer ensuring access to high-quality lung cancer screening for Veterans at risk
Drew Moghanaki shared a post on X: "Thank you, GO2 for Lung Cancer for your…
Jul 15, 2024, 14:04 |
Insight
Drew Moghanaki: RCT for oligoprogressive stage IV cancer leveraging “pulsed” SBRT
Drew Moghanaki shared on X: "NEW: phase II randomized clinical trial for oligoprogressive stage IV…
Jul 6, 2024, 12:24 |
Blog
Drew Moghanaki: List of videos for US Veterans with lung cancer
Drew Moghanaki shared a post on X: . "If you know any US Veterans with…
Jun 26, 2024, 05:25 |
Blog
Aditya Juloori: Greys Anatomy highlights COSINR trial at UChicago Cancer Center
Drew Moghanaki shared a post by Aditya Juloori, radiation oncologist at UChicago Medicine on X: “Wait. What?…
Jun 24, 2024, 07:51 |
Blog
A new review sheds light on radiographic scars developing after lung SBRT
Drew Moghanaki shared on X: "A new review is published that sheds light on radiographic scars…
Jun 22, 2024, 01:17 |
Blog
Drew Moghanaki: Contemporary data on lung cancer screening rates in the US
Drew Moghanaki shared a post on X: "The American Cancer Society publishes contemporary data on lung…
Jun 18, 2024, 09:36 |
Blog
Drew Moghanaki: Dr. Wen-Zhao Zhong reminding us of the fanfare around drugs and surgery for NSCLC
Drew Moghanaki shared on X: "Dr. Wen-Zhao Zhong presents a slide at ELIXR24 reminding us…
Jun 14, 2024, 20:47 |
Blog
Drew Moghanaki: Research suggests smoking duration should be considered more important
Drew Moghanaki shared a post on X: "The belief that 'tobacco pack-year' is the most important…
Jun 14, 2024, 20:04 |
Blog
Drew Moghanaki: Jonathan Spicer has us debating the treatment for stage III NSCLC
Drew Moghanaki shared a post on X: "Just like that, the clairvoyant Jonathan Spicer now has…
Jun 7, 2024, 10:53 |
Blog
Drew Moghanaki: All patients getting CRT for locally advanced NSCLC must undergo EGFR testing
Drew Moghanaki shared on X/Twitter: ''This presentation by Suresh S. Ramalingam marks a historical moment…
Jun 6, 2024, 02:10 |
Blog
Drew Moghanaki: Why does Neha Vapiwala deserve our vote to be the next ASTRO president
Drew Moghanaki shared on X/Twitter: "With ASTRO elections coming up this week, why do so many…
Jun 2, 2024, 12:03 |
Blog
Drew Moghanaki: A look back at arguably the most important phase III RCT ever completed in the history of oncology
Drew Moghanaki shared on X: "Here is a look back at arguably the most important…
May 30, 2024, 09:17 |
Insight
Drew Moghanaki: How family history may be more important than smoking history by Pan-Chyr Yang et al
Drew Moghanaki shared a post on X: “Here is the abstract for a 78,000 patient…
May 22, 2024, 08:23 |
Blog
Drew Moghanaki: Results of the SEISMIC trial are shared in a few posters at ATS2024
Drew Moghanaki shared on X: “The results of the SEISMIC trial are shared in a few…
May 21, 2024, 13:21 |
Blog
Drew Moghanaki: The VA is studying how to expand lung cancer screening eligibility criteria
Drew Moghanaki shared on X: “The VA is studying how to expand lung cancer screening eligibility…
May 21, 2024, 06:36 |
Insight
Drew Moghanaki: A federal government official teaches a room full of pulmonologists
Drew Moghanaki shared on X: “A federal government official teaches a room full of pulmonologists…
May 21, 2024, 02:39 |
Blog
Drew Moghanaki: How mediastinal LNs are sampled during lung surgery
Drew Moghanaki shared on X/Twitter: "Thank you, Linda Martin, for sharing a link to this video,…
May 14, 2024, 15:21 |
Insight
Drew Moghanaki: Here is a landmark study from 1960 published by University College London
Drew Moghanaki shared on X: "Here is a landmark study from 1960 published by University…
May 12, 2024, 14:15 |
Blog
Drew Moghanaki: The powerful Terri Ann DiJulio's lung cancer story is one of the most inspiring I have ever heard
Drew Moghanaki shared a post on X: "I look forward to this event with my thoughtful…
Apr 27, 2024, 10:46 |
Blog
Drew Moghanaki: Our residents at UCLA experienced a truly engaging lecture about SCLC by Jie Deng
Drew Moghanaki, Lung Cancer Specialist at UCLA Health Jonsson Cancer Center, shared on X/Twitter: "Our residents…
Apr 20, 2024, 18:50 |
Blog
Drew Moghanaki: The nomination slate for the next ASTRO President has been announced
Drew Moghanaki, Lung Cancer Specialist at UCLA Health Jonsson Cancer Center, shared a post on…
Apr 17, 2024, 18:57 |
Blog
Drew Moghanaki: A primer to help manage disagreements that feel like a threat
Drew Moghanaki, Lung Cancer Specialist at UCLA Health Jonsson Cancer Center, shared on X/Twitter: "Here’s…
Apr 11, 2024, 16:58 |
Blog
Drew Moghanaki: Why programs that focus on lung health are very effective
Drew Moghanaki, Lung Cancer Specialist at UCLA Health Jonsson Cancer Center, shared a post on…
Apr 9, 2024, 09:10 |
Career
Drew Moghanaki: Dr. Matt Rettig has received the 2024 John Blair Barnwell Award for outstanding achievement in clinical science
Drew Moghanaki, Lung Cancer Specialist at UCLA Health Jonsson Cancer Center, shared a post on…
Apr 4, 2024, 13:39 |
Blog
Drew Moghanaki: It's reassuring to see longitudinal data aligning with the recommendations we provide patients with stage I NSCLC deciding between surgery and SBRT during usual care
Mar 29, 2024, 22:30 |
Blog
Brendon Stiles: Let's talk about PACIFIC 2
Brendon Stiles, Professor and Chief, Thoracic Surgery and Surgical Oncology at Montefiore Health System, posted…
Mar 28, 2024, 14:38 |
Blog
Drew Moghanaki: Is there another healthcare system in the US with a similar commitment to reducing lung cancer mortality?
Drew Moghanaki, Lung Cancer Specialist at UCLA Health Jonsson Cancer Center, shared a post on…
Mar 19, 2024, 21:10 |
Blog
Drew Moghanaki: Having finally met the amazing Kim Norris, I now understand why the LCFA is so well connected to the academic lung cancer community
Drew Moghanaki, Chief of Thoracic Oncology at UCLA Department of Radiation Oncology, shared a post…
Mar 5, 2024, 14:28 |
Blog
Drew Moghanaki: A critical report from Amsterdam demonstrates misdiagnosed drug-related pneumonitis
Drew Moghanaki, Professor, Chief of Thoracic Oncology at UCLA Department of Radiation Oncology, recently shared…
Mar 5, 2024, 00:54 |
Blog
Stephen V. Liu: Report Clinical Lung Cancer shows improving lung cancer survival in the Veterans Administration
Stephen V. Liu, Director of Thoracic Oncology and Developmental Therapeutics at Lombardi Comprehensive Cancer Center,…
Feb 20, 2024, 19:26 |
Blog
Drew Moghanaki: Hollywood's nihilistic portrayal of cancer is potentially blind to the consequences on those of us in the trenches caring for people with this disease
Drew Moghanaki, Professor, Chief of Thoracic Oncology Service at David Geffen School of Medicine at…
Feb 15, 2024, 12:32 |
Insight
Drew Moghanaki: The importance of more than 110% hotspots in lung SBRT plans
Drew Moghanaki, Professor, Chief of Thoracic Oncology Service at David Geffen School of Medicine at…
Feb 11, 2024, 15:07 |
Blog
Drew Moghanaki: This year's The Radio-surgery Society Scientific Meeting, the agenda assumes "Some SBRT" is better than "No SBRT"
Drew Moghanaki, Chief of Thoracic Oncology in the UCLA Department of Radiation Oncology, shared a post…
Jan 28, 2024, 15:04 |
Blog
Drew Moghanaki: RECIST over-classified 'progression' in 81% of cases without progression.
Drew Moghanaki, Chief of Thoracic Oncology in the UCLA Department of Radiation Oncology, shared a post…
Jan 14, 2024, 18:03 |
Insight
Drew Moghanaki: I'm not surprised by the excellent quality of the manuscript
Drew Moghanaki, Lung Cancer Specialist at UCLA Health Jonsson Cancer Center and VA Greater Los…
Jan 9, 2024, 18:51 |
Blog
Drew Moganaki about smoking cessation
Drew Moghanaki, Lung Cancer Specialist at UCLA Health Jonsson Cancer Center, shared a post on…
Jan 9, 2024, 01:34 |
Blog
Drew Moghanaki: Evidence demonstrating the benefits of lung cancer screening
Drew Moghanaki, Lung Cancer Specialist at UCLA Health Jonsson Cancer Center, shared a post on…
Jan 8, 2024, 14:21 |
Blog
Drew Moghanaki shared a study from Duke University on Stage I NSCLC
Drew Moghanaki, Lung Cancer Specialist at UCLA Health Jonsson Cancer Center, shared a post on…
Jan 6, 2024, 17:26 |
Blog
Jonathan Spicer: It’s more often than not micrometastatic disease
Jonathan Spicer, Medical Director of the McGill Thoracic Oncology Program, shared a post by Drew…
Dec 30, 2023, 17:33 |
Blog
Drew Moghanaki: Roswell Park's 13-year experience with single-fraction lung Stereotactic body radiation therapy (SBRT)
Drew Moghanaki, Lung Cancer Specialist at UCLA Health Jonsson Cancer Center, shared a post on…
Dec 13, 2023, 17:07 |
Insight
Drew Moghanaki: This insightful study by Michael Farris reminds us that communication gaps affect patient care
Drew Moghanaki, Lung Cancer Specialist at UCLA Health Jonsson Cancer Center, shared on X/Twitter: "I…
Nov 27, 2023, 16:40 |
Insight
Drew Moghanaki: A slide presented by Fiona McDonald at WCLC19 teaches us
Drew Moghanaki, Lung Cancer Specialist at UCLA Health Jonsson Cancer Center, shared on X/Twitter: ''Here…
Sep 17, 2023, 18:35 |
Drugs
,
Insight
Drew Moghanaki: Here is a trio of ongoing adjuvant studies for patients with stage IA NSCLC.
Drew Moghanaki, Co-Chair of VA Lung Precision Oncology Program Biomarker Subworkgroup at U.S. Department of…
All:
59
Posts:
1 - 100
Making Personal Experience a Political Priority: Insights from EU Commissioner Stella Kyriakides
Zolbetuximab is now approved by the US FDA
Highlights from NFCR’s GSAC24
SIOP Honoured Hansjörg Riehm with the 2024 Lifetime Achievement Award
Margaret Foti has received the 2024 Beacon Award for Women Leaders in Oncology
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube